Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Marks Lilly, Director. Officer active across 1 company, notably Orthofix Medical Inc.. In total, 2 reports have been recorded. History available since 21 June 2021. The latest transaction was disclosed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Lilly Marks is a Director of Orthofix Medical Inc. As a board member, she participates in overseeing the company's activities and making strategic decisions. Her experience and skills in corporate governance are essential for guiding Orthofix Medical Inc. in its growth and innovation objectives.